These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 17689516

  • 1. Automated monitoring of C2 and C0 blood levels of mycophenolic acid and cyclosporine on the Abbott Architect c8000.
    Boer K, Brehmer-Streck S, Deufel T, Schmidt D, Kiehntopf M.
    Clin Biochem; 2007 Oct; 40(15):1163-7. PubMed ID: 17689516
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 3. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
    Boer K, Deufel T, Schmidt D, Streck S, Kiehntopf M.
    Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
    Yargui L, Berhoune A.
    Transplant Proc; 2009 Nov; 41(9):3713-9. PubMed ID: 19917373
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M.
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method.
    van Gelder T, Domke I, Engelmayer J, de Fijter H, Kuypers D, Budde K, Koeger R, Luthe H, Oellerich M.
    Ther Drug Monit; 2009 Apr; 31(2):218-23. PubMed ID: 19214147
    [Abstract] [Full Text] [Related]

  • 7. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.
    Cattaneo D, Zenoni S, Murgia S, Merlini S, Baldelli S, Perico N, Gotti E, Ottomano C, Crippa A, Remuzzi G.
    Clin Chim Acta; 2005 May; 355(1-2):153-64. PubMed ID: 15820490
    [Abstract] [Full Text] [Related]

  • 8. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
    Olejnik Y, Elaerts S, Bonardet A, Chong G, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 May; 37(1):172-4. PubMed ID: 15808584
    [Abstract] [Full Text] [Related]

  • 9. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S, Olejnik Y, Bonardet A, Garrigue V, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 May; 37(1):167-71. PubMed ID: 15808583
    [Abstract] [Full Text] [Related]

  • 10. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
    Dasgupta A, Tso G, Chow L.
    Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
    [Abstract] [Full Text] [Related]

  • 11. The Emit® 2000 Cyclosporine Specific Assay, Extended Range: development of an application protocol for the V-Twin® analyzer.
    Morjana N, Yau H, Rea D, Ruttle D, Jones H, Siefring G, Christenson R.
    Biotechnol Appl Biochem; 2011 May; 58(6):476-82. PubMed ID: 22172110
    [Abstract] [Full Text] [Related]

  • 12. The Abbott Architect c8000: analytical performance and productivity characteristics of a new analyzer applied to general chemistry testing.
    Pauli D, Seyfarth M, Dibbelt L.
    Clin Lab; 2005 May; 51(1-2):31-41. PubMed ID: 15719702
    [Abstract] [Full Text] [Related]

  • 13. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
    LeGatt DF, Shalapay CE, Cheng SB.
    Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
    [Abstract] [Full Text] [Related]

  • 14. Comparison of automated ACMIA and EMIT immunoassays for whole blood cyclosporin monitoring.
    Dessars B, Cotton F, Thiry P, Gulbis B.
    Clin Lab; 2003 Nov; 49(3-4):135-40. PubMed ID: 12705695
    [Abstract] [Full Text] [Related]

  • 15. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay.
    Kuhn J, Prante C, Kleesiek K, Götting C.
    Clin Biochem; 2009 Jan; 42(1-2):83-90. PubMed ID: 18996104
    [Abstract] [Full Text] [Related]

  • 16. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M.
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
    Huet E, Morand K, Blanchet B, Astier A, Hulin A.
    Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
    Pourfarziani V, Taheri S.
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
    [Abstract] [Full Text] [Related]

  • 20. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients.
    Davies RA, Veinot JP, Williams K, Haddad H, Baker A, Donaldson J, Pugliese C, Struthers C, Masters RG, Hendry PJ, Mesana T.
    Transplant Proc; 2007 Dec; 39(10):3334-9. PubMed ID: 18089382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.